Charlotte Tyson

439 total citations
7 papers, 85 citations indexed

About

Charlotte Tyson is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Charlotte Tyson has authored 7 papers receiving a total of 85 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Charlotte Tyson's work include Bladder and Urothelial Cancer Treatments (3 papers), Cancer Genomics and Diagnostics (2 papers) and Renal cell carcinoma treatment (2 papers). Charlotte Tyson is often cited by papers focused on Bladder and Urothelial Cancer Treatments (3 papers), Cancer Genomics and Diagnostics (2 papers) and Renal cell carcinoma treatment (2 papers). Charlotte Tyson collaborates with scholars based in United Kingdom, Spain and Netherlands. Charlotte Tyson's co-authors include Aaron Prendergast, Kelly Mousa, Alejo Rodríguez‐Vida, James Larkin, Poulam M. Patel, Begoña P. Valderrama, Christy Ralph, C. Suárez Rodríguez, María José Méndez-Vidal and Hilary Glen and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Medical Genetics.

In The Last Decade

Charlotte Tyson

6 papers receiving 84 citations

Peers

Charlotte Tyson
C Olier Spain
Marion Piedmonte United States
Philip Badman United Kingdom
Lindsey Beffa United States
F Marmé Germany
Charlotte Tyson
Citations per year, relative to Charlotte Tyson Charlotte Tyson (= 1×) peers Roi Tschernichovsky

Countries citing papers authored by Charlotte Tyson

Since Specialization
Citations

This map shows the geographic impact of Charlotte Tyson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Tyson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Tyson more than expected).

Fields of papers citing papers by Charlotte Tyson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Tyson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Tyson. The network helps show where Charlotte Tyson may publish in the future.

Co-authorship network of co-authors of Charlotte Tyson

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Tyson. A scholar is included among the top collaborators of Charlotte Tyson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Tyson. Charlotte Tyson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Tyson, Charlotte, Xiaoqin Cao, A. Burak Ozbay, et al.. (2023). EPH232 The Large Hidden Prevalence Rate of Cancer Using Backward Induction Method Reveals Screening Opportunity in Earlier Stages. Value in Health. 26(6). S205–S205.
2.
Szabados, Bernadett, Alejo Rodríguez‐Vida, Ignacio Durán, et al.. (2021). Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial. European Urology Oncology. 4(3). 456–463. 19 indexed citations
3.
Gaba, Faiza, Dalya Marks, Dhivya Chandrasekaran, et al.. (2021). Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study. Journal of Medical Genetics. 59(2). jmedgenet–2020. 12 indexed citations
4.
Rodríguez, C. Suárez, James Larkin, Poulam M. Patel, et al.. (2021). Clinical activity of durvalumab and savolitinib in MET-driven, metastatic papillary renal cancer.. Journal of Clinical Oncology. 39(15_suppl). 4511–4511. 12 indexed citations
5.
Szabados, Bernadett, Alejo Rodríguez‐Vida, Ignacio Durán, et al.. (2020). 199O A phase II study investigating neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive bladder cancer: Final analysis. Annals of Oncology. 31. S1319–S1319. 3 indexed citations
6.
Gaba, Faiza, Naveena Singh, W. Glenn McCluggage, et al.. (2020). Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial. International Journal of Gynecological Cancer. 31(2). 286–291. 26 indexed citations
7.
Rodríguez, C. Suárez, James Larkin, Poulam M. Patel, et al.. (2020). Overall survival results for durvalumab and savolitinib in metastatic papillary renal cancer.. Journal of Clinical Oncology. 38(6_suppl). 619–619. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026